June Sees UK Ivabradine Prices More Than Treble
Pricewatch UK – June 2021
Ivabradine exhibited interesting pricing dynamics in the UK in June, with the average cost of the heart failure treatment more than trebling despite the lowest offer in the market remaining stable.
You may also be interested in...
Benign prostatic hyperplasia treatment indoramin topped the UK’s steepest generic price rises in September with an average price that more than trebled, according to the latest figures from WaveData.
Gentamicin prices saw huge increases in the UK in May, with the average shooting up by almost 600%.
A report adopted by the European Parliament calling for measures to support a “greater market presence for generic and biosimilar medicines” has been welcomed by Medicines for Europe.